RORγt Inverse agonist 6

Research use only, not for human use.

RORγt Inverse agonist 6 is an agonist of RORγt inverse. RORγt Inverse agonist 6 can be used in research on Th17-driven autoimmune diseases.

RORγt Inverse agonist 6 is an agonist of RORγt inverse. RORγt Inverse agonist 6 can be used in research on Th17-driven autoimmune diseases.(In Vivo):RORγt Inverse agonist 6 (30 mg/kg; p.o.) inhibits the expression level of IL-17A by 59% compared to the vehicle after the oral administration at the tested dose. RORγt Inverse agonist 6 suppresses IL-17A gene expression by IL-23 stimulation in a mouse pharmacodynamics model. RORγt Inverse agonist 6 (1 mg/kg; p.o.) exhibits improved drug exposure with AUC of 1289 ng h/mL.

——

RORγt Inverse agonist 6 (compound 43) suppresses IL-17A gene expression by IL-23 stimulation in a mouse pharmacodynamics model.RORγt Inverse agonist 6 (compound 43) exhibits improved drug exposure (mouse AUC: 1289 ng?h/mL at 1 mg/kg, po).RORγt Inverse agonist 6 (compound 43, 30 mg/kg, po, b.i.d) inhibits the expression level of IL-17A by 59% compared to the vehicle after the oral administration at the tested dose. Animal Model:Mice.Dosage:30 mg/kg.Administration:Orally twice: at 30 min before and 8 h after IL-23 administration.Result:Inhibited the expression level of IL-17A by 59% compared to the vehicle after the oral administration at the tested dose.

——

Nuclear Receptor/Transcription Factor

ROR

ADC Linker

——

——

1887161-80-9

565.03

C28H29ClN6O5

>98% (HPLC)

In Vitro:?DMSO : 50 mg/mL (88.49 mM)

CC(C)n1c2ccc(NC(=O)N3CCO[C@H](C3)C(=O)Nc3ccc(C#N)c(Cl)c3)cc2c(=O)n(CC2CC2)c1=O

——

(-20℃)

With Ice Pack

≥ 2 years